Disclaimer:

    The views, information, or opinions expressed in the Industry News RSS feed belong solely to the author and do not necessarily represent those of IDEX Health & Science and its employees.

    Lumibird postpones growth target on lidar delays

    Article obtained from Optics.org RSS Feed.

    €150M annual turnover now expected by French photonics firm to be achieved in 2022, a year later than planned.

    READ MORE
    Jan, 28 2020 |

    IDEX Health & Science is the global authority in fluidics and optics, bringing to life advanced optofluidic technologies with our products, people, and engineering expertise. Intelligent solutions for life.